Tasquinimod
CAS: 254964-60-8
Ref. 3D-FT76139
| 1mg | Descontinuado | ||
| 2mg | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado |
Informação sobre produto
Nome:
Tasquinimod
Sinónimos:
- 1,2-Dihydro-4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]-3-quinolinecarboxamide
- 3-Quinolinecarboxamide, 1,2-dihydro-4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]-
- 4-Hydroxy-5-methoxy-N-methyl-1-methyl-2-oxo-N-(4-trifluoromethylphenyl)-1,2-dihydroquinoline-3-carboxamide
- Abr 215050
- Abr-5050
- N-Methyl-N-(4-trifluoromethylphenyl)-1,2-dihydro-4-hydroxy-5-methoxy-1-methyl-2-oxoquinoline-3-carboxamide
Descrição:
Tasquinimod is a cytostatic agent that binds to the Toll-like receptor, which is an innate immune receptor that plays a role in the regulation of inflammation. It is also a potent inhibitor of matrix metalloproteinase (MMP)-9 activity, which is important for tumor invasion and metastasis. Tasquinimod has been shown to inhibit tumor cell proliferation and induce apoptosis in various types of cancer cells including prostate cancer. This drug has minimal toxicity and does not affect healthy cells. Tasquinimod can be used to treat solid tumours such as prostate cancer.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
406.36 g/mol
Fórmula:
C20H17F3N2O4
Pureza:
Min. 95%
InChI:
InChI=1S/C20H17F3N2O4/c1-24(12-9-7-11(8-10-12)20(21,22)23)18(27)16-17(26)15-13(25(2)19(16)28)5-4-6-14(15)29-3/h4-10,26H,1-3H3
Chave InChI:
InChIKey=ONDYALNGTUAJDX-UHFFFAOYSA-N
SMILES:
COc1cccc2c1c(O)c(C(=O)N(C)c1ccc(C(F)(F)F)cc1)c(=O)n2C
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
